KR950701818A - 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues) - Google Patents
탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues)Info
- Publication number
- KR950701818A KR950701818A KR1019940704525A KR19940704525A KR950701818A KR 950701818 A KR950701818 A KR 950701818A KR 1019940704525 A KR1019940704525 A KR 1019940704525A KR 19940704525 A KR19940704525 A KR 19940704525A KR 950701818 A KR950701818 A KR 950701818A
- Authority
- KR
- South Korea
- Prior art keywords
- arg
- leu
- gly
- lys
- ile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
본 발명의 신규한 펩타이드는 다이놀핀 동족체로서 내인성 다이놀핀과 유사한 활성을 갖지만 내인성 다이놀핀과 관련하여 탈-Try 또는 탈-Try-Gly된 것이다. 이 펩타이드는 마약성 진통제의 활성에 상승작용을 하도록 하고 및/또는 금단증상을 차단하도록 마약성 진통제에 내성을 갖는 숙주에서 투여하는 치료적인 용도를 갖는다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 하기 서열을 갖는 펩타이드 :Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn (SEQ IN NO :4) ;Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp (SEQ IN NO: 5) ;Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp(SEQ IN NO:6) ;Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys (SEQ IN NO:7);Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu(SEQ IN NO:8);Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys(SEQ IN NO:9);Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro(SEQ IN NO:10);Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg(SEQ IN NO:11); 여기서, C-말단은 산 또는 아미드형태이다.
- 하기 서열을 갖는 펩타이드;Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln (SEQ IN NO :13);Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn (SEQ IN NO :14);Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp(SEQ IN NO :15);Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp(SEQ IN NO :16);Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys(SEQ IN NO :17);Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu(SEQ IN NO :18);
- 마약성 진통제 금단증상을 차단하고 및/또는 마약성 진통제와 함께 투여되어 상승작용을 일으키도록 하는 데 효과적인 양의 다이놀핀 동족체를 투여하는데 투여된 다이놀핀 동족체가 N-말단에서 탈-Tyr또는 탈-Tyr-Gly인 것을 포함하는, 마약성 진통제가 내성을 갖는 환자의 치료방법.
- 제10항에 있어서, 다이놀핀 동족제가 약제학적으로 수용가능한 용액에 투여되는 치료방법.
- 제10항에 있어서, 다이놀핀 동족제가 최소한 6아미노산 잔기를 갖는 치료방법.
- 제10항에 있어서, 다인놀핀, 다이놀핀 동족제가 C-말단에서 아미드화 되는 치료방법.
- 제10항에 있어서, 다이놀핀 동족제가 내인성 다이놀핀의 아미노산 서열에 비하여 증가된 생체내 안정성 또는 배좌안정성을 치료방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89792092A | 1992-06-12 | 1992-06-12 | |
US07/897,920 | 1992-06-12 | ||
PCT/US1993/005161 WO1993025217A1 (en) | 1992-06-12 | 1993-06-01 | Des-tyr dynorphin analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950701818A true KR950701818A (ko) | 1995-05-17 |
Family
ID=25408662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940704525A KR950701818A (ko) | 1992-06-12 | 1993-06-01 | 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues) |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0652765A4 (ko) |
JP (1) | JPH08501075A (ko) |
KR (1) | KR950701818A (ko) |
AU (1) | AU4399093A (ko) |
CA (1) | CA2137916A1 (ko) |
CZ (1) | CZ281630B6 (ko) |
FI (1) | FI945811A (ko) |
HU (1) | HUT70160A (ko) |
NO (1) | NO944778L (ko) |
RU (1) | RU95106651A (ko) |
WO (1) | WO1993025217A1 (ko) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482930A (en) * | 1993-06-09 | 1996-01-09 | The Regents Of The University Of California | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |
US7220737B1 (en) | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
EP1009407B1 (en) | 1997-09-04 | 2004-04-28 | Novoneuron, Inc. | Noribogaine in the treatment of pain and drug addiction |
US6437092B1 (en) | 1998-11-06 | 2002-08-20 | Conjuchem, Inc. | Conjugates of opioids and endogenous carriers |
US7601691B2 (en) | 1999-05-17 | 2009-10-13 | Conjuchem Biotechnologies Inc. | Anti-obesity agents |
EP1591453A1 (en) | 1999-05-17 | 2005-11-02 | ConjuChem Inc. | Modified peptides yy and conjugates thereof |
US6849714B1 (en) | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
US6887470B1 (en) | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
US6706892B1 (en) | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
JP2004520395A (ja) | 2001-02-02 | 2004-07-08 | コンジュケム,インコーポレーテッド | 長期持続性成長ホルモン放出因子誘導体 |
EP1360202B1 (en) | 2001-02-16 | 2008-05-21 | ConjuChem Biotechnologies Inc. | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
US8362007B1 (en) | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
US8741891B1 (en) | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
MX2013000733A (es) | 2010-07-23 | 2013-05-30 | Demerx Inc | Composiciones de noribogaina. |
EP2481740B1 (en) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
EP2788003A4 (en) | 2011-12-09 | 2015-05-27 | Demerx Inc | PHOSPHATESTER OF NORIBOGAIN |
EP2807168A4 (en) | 2012-01-25 | 2015-10-14 | Demerx Inc | SYNTHETIC VOACANGINE |
US9150584B2 (en) | 2012-01-25 | 2015-10-06 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
EP2934541A4 (en) | 2012-12-20 | 2016-08-03 | Demerx Inc | NORIBOGAINE SUBSTITUTE |
US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
US10428115B2 (en) | 2013-05-24 | 2019-10-01 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain |
US9550789B2 (en) | 2014-06-18 | 2017-01-24 | Demerx, Inc. | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10511077A (ja) * | 1994-08-26 | 1998-10-27 | ナンシー、 エム. リー、 | N末端基で切断されたダイノルフィン類似体を用いた鎮痛方法 |
-
1993
- 1993-06-01 JP JP6501537A patent/JPH08501075A/ja active Pending
- 1993-06-01 HU HU9403563A patent/HUT70160A/hu unknown
- 1993-06-01 EP EP93914274A patent/EP0652765A4/en not_active Withdrawn
- 1993-06-01 CA CA002137916A patent/CA2137916A1/en not_active Abandoned
- 1993-06-01 WO PCT/US1993/005161 patent/WO1993025217A1/en not_active Application Discontinuation
- 1993-06-01 CZ CZ943131A patent/CZ281630B6/cs unknown
- 1993-06-01 RU RU95106651/14A patent/RU95106651A/ru unknown
- 1993-06-01 KR KR1019940704525A patent/KR950701818A/ko not_active Application Discontinuation
- 1993-06-01 AU AU43990/93A patent/AU4399093A/en not_active Abandoned
-
1994
- 1994-12-09 FI FI945811A patent/FI945811A/fi not_active Application Discontinuation
- 1994-12-09 NO NO944778A patent/NO944778L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1993025217A1 (en) | 1993-12-23 |
CA2137916A1 (en) | 1993-12-23 |
HUT70160A (en) | 1995-09-28 |
NO944778L (no) | 1995-02-10 |
CZ281630B6 (cs) | 1996-11-13 |
JPH08501075A (ja) | 1996-02-06 |
EP0652765A1 (en) | 1995-05-17 |
NO944778D0 (no) | 1994-12-09 |
FI945811A (fi) | 1995-02-06 |
FI945811A0 (fi) | 1994-12-09 |
CZ313194A3 (en) | 1995-08-16 |
RU95106651A (ru) | 1996-12-27 |
EP0652765A4 (en) | 1997-04-09 |
HU9403563D0 (en) | 1995-02-28 |
AU4399093A (en) | 1994-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950701818A (ko) | 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues) | |
KR890001572A (ko) | 표유동물에게 히알우론산을 원격 투여하는 방법 | |
MX9402339A (es) | Formulacion de proteina. | |
FI963871A (fi) | Farmaseuttinen formulointi tekijän VIII tai tekijän IX antamiseksi ihonalaisesti, lihaksensisäisesti tai ihonsisäisesti | |
KR970706842A (ko) | 아실화된 인슐린 동족체(Acylated Insulin Analogs) | |
Klein et al. | Pressor and cardioaccelerator effects of gamma MSH and related peptides | |
RU2223970C2 (ru) | Лечение ожирения | |
KR900003205A (ko) | 제약 화합물 | |
US4684624A (en) | Method of treating cerebral ischemia | |
EP0317573B1 (en) | Antipyretic and anti-inflammatory peptides | |
SG129211A1 (en) | Therapeutic molecules | |
KR960702847A (ko) | 생물학적 활성의 바소프레신 유사체 | |
US3864481A (en) | Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor | |
US4481191A (en) | Method for controlling blood pressure | |
DE60133654D1 (de) | Arzneimittel enthaltend analgetische peptide | |
ES2842523T3 (es) | Métodos y composiciones para el tratamiento de la artritis | |
KR950702574A (ko) | 펩티드 폐 계면활성제 및 치료용 혼합물(Peptide Lung Surfactants and Therapeutic Combinations) | |
Mann et al. | Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin | |
RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
EP0016136A1 (en) | Inhibition by peptides of tolerance to and dependence on morphine | |
KR950704358A (ko) | 카텝신 l 특이적 저해 폴리펩티드 | |
Takeuchi et al. | Modification of effects of biologically active peptides, caused by enzyme treatment, on the excitability of identifiable giant neurones of an African giant snail (Achatina fulica Férussac) | |
KR960706503A (ko) | CXC 인터크린 분자의 펩타이드 억제제(Peptide inhibitors of CXC intercrine molecules) | |
US5741774A (en) | Use of a cytokine regulatory agent to treat rheumatoid arthritis | |
WO1993006841A1 (en) | A peptide analog |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |